Payer Sciences
Eileen Frain has extensive experience in various roles within the marketing and communications industry. Eileen is currently serving as the Senior Director of Client Engagement at Payer Sciences since May 2022. Prior to this, they worked at Jump Marketing Services as the SVP of Client Services from September 2017 to October 2022. In 2014, Eileen worked at FCBCURE as the VP of Group Account Supervisor, managing the Vertex Pharmaceuticals account. Eileen also held positions at Area 23 as the VP of Account Supervisor from July 2013 to June 2014, IGNITE Health as an Account Director from February 2012 to June 2013, and Rosetta as an Account Director from June 2007 to September 2011. Eileen began their career at JPMorgan Chase as a Vice President of Marketing from April 2000 to January 2005.
Eileen Frain's education history includes a Bachelor of Arts degree in English from Montclair State University. Additionally, they earned a Certificate in Project Management Professional from Rutgers Business School.
Payer Sciences
Tasked with tackling a labyrinth of payers and organized customers, with limited resources, payer marketers can sometimes feel trapped between a rock and—well…you know. Which is why our clients need an agency that knows how to rock in a hard space. Since day one, Payer Sciences has approached managed markets from a different angle. We firmly believe the truth lies in the data. We relentlessly analyze what formulary decision-makers and prescribers actually do, revealing patterns and practices that impact stakeholders across the treatment journey, and drive bottom-line results. This disciplined approach requires an investment in sharp minds and multiple perspectives. To that end, Payer Sciences has assembled a flat and flexible organization, with analytics, consulting and communications living together under one roof—as one fully aligned team—so that we’re always ready to rock. No matter how hard the space. Payer Sciences is part of Publicis Health North America, and a subsidiary of the Publicis Group (OTCQX: PUBGY).